(Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly ...

As winter brings a rise in coughs, colds, and fevers, it’s often hard to tell if it’s just a seasonal viral, the flu, or ...

Plans that invest in real-time visibility, clinical data exchange, and workflows built around proactive action will protect ...

A start-up should always have a “plan B” to provide a critical safety net. A considerable and expensive amount of redundant lab equipment can sit idle if that pivot arises and prompts a significant ...

Co-Diagnostics (CODX) announced the formation of a newly organized, artificial intelligence business unit, led by Chief Technology & AI Officer ...

Victoria is ramping up its biosecurity defences against H5N1 bird flu, with new federal support to boost emergency preparedness and rapid response ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

By leveraging advanced Polymerase Chain Reaction (PCR) technology with streamlined testing for a broad range of gastrointestinal (GI) bacterial pathogens from a single stool swab sample, the panels ...

According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...

A mechanical engineer by training, he is known for his work in fluid mechanics, biomedical engineering and affordable health ...

A mechanical engineer by training, he is known for his work in fluid mechanics, biomedical engineering and affordable health ...